Recon: Abbott to acquire Exact Sciences in $21B deal; Merck KGaA pairs with Valo for AI drug discovery
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States